PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
11-Jun-2020 Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages of 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Vertex Pharmaceuticals Incorporated
11-Jun-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds Cancer Research UK
11-Jun-2020 RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib RedHill Biopharma
11-Jun-2020 Genmab and AbbVie Announce Broad Oncology Collaboration Genmab
11-Jun-2020 Pierre Fabre receives European Commission Marketing Authorisation for BRAFTOVI® (encorafenib) in combination with Erbitux® (cetuximab) for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC) who have received prior systemic therapy Pierre Fabre
11-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
11-Jun-2020 Ashvattha Therapeutics Subsidiary Orpheris Announces Completion of Phase 1 Study of OP-101 Subcutaneous Formulation Ashvattha Therapeutics
11-Jun-2020 Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases Dupixent
11-Jun-2020 Investment Plan for Europe: European Investment Bank to provide BioNTech with up to €100 million in debt financing for COVID-19 vaccine development and manufacturing The European Investment Bank
11-Jun-2020 Biophytis Receives MHRA Approval to Initiate the COVA Clinical Trial in the UK with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure BIOPHYTIS
11-Jun-2020 Bone Therapeutics announces Annual General Meeting results and confirms outlook for 2020 Bone Therapeutics
11-Jun-2020 Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies About Zelluna Immunotherapy
11-Jun-2020 Alnylam Announces Publication of ENVISION Phase 3 Study Results for Givosiran in The New England Journal of Medicine Alnylam Pharmaceuticals, Inc.
11-Jun-2020 (Covid-19) Impact Analysis : Allergic Rhinitis Drugs Market Size, Trends, Analysis, Demand, Outlook and Forecast to 2026 Qurate Business Intelligence
10-Jun-2020 The Creative Engagement Group acquires Cormis healthcare consultancy The Creative Engagement Group
10-Jun-2020 CPhI Middle East & Africa to debut in Saudi Arabia in 2021 CPhI MEA
09-Jun-2020 (Covid-19) Impact Analysis : Ptca Coronary Drug Eluting Balloons Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast 2026 B.Braun, Spectranetics, Concept Medical, Eurocor, Lifetech, Maxcor, Micell, Qualimed, Acrostak Qurate Business Intelligence
08-Jun-2020 Press Launch of hVIVO COVID Clear Test, the most accurate antibody test available to UK employers to help get people back to work hVIVO
08-Jun-2020 UCB Shares Breadth of Innovative New Data from Rheumatology Portfolio for EULAR 2020 E-Congress UCB
08-Jun-2020 AbbVie at EULAR - RINVOQ™ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients AbbVie